Ashwin Somasundaram Archives - UNC Lineberger Comprehensive Cancer Center

June 3, 2026

Becker’s Oncology: The promises — and challenges — of the FDA’s real-time clinical trial model

UNC Lineberger members will share their latest research findings and clinical insights during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.

The rise of colorectal cancer cases in people under 45 has steadily increased, prompting concern among oncologists and researchers. Ashwin Somasundaram, MD, talks about colorectal cancer and this concerning trend.

Human colon cancer cells with the cell nuclei stained red and the protein E-cadherin stained green. E-cadherin is a cell adhesion molecule and its loss signals a process known as the epithelial-mesenchymal transition in which cells acquire the ability to migrate and become invasive.

UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer.

Tag: Ashwin Somasundaram

Becker’s Oncology: The promises — and challenges — of the FDA’s real-time clinical trial model

Becker’s Hospital Review: ‘The most significant change in 20 years’: Cancer centers prepare for pancreatic cancer drug demand

UNC Lineberger members to present at American Society of Clinical Oncology Annual Meeting

WECT: Blue Ribbon Run to host cancer research symposium in Wilmington

The News & Observer: New cancer drugs could double survival time. What NC doctors want you to know

ABC11: Mentors remember former Miss NC Carrie Everett: ‘Our forever queen’

WRAL: After former Miss North Carolina’s death, doctor says young cancer diagnoses becoming more common

WRAL: Diagnosis: Young, The New Face of Cancer in NC

Gastrointestinal oncologist discusses increase in younger patients with colorectal cancer

Immunotherapy and targeted therapy combination proves effective against metastatic colorectal cancer